As of 26 Oct 2024, Regeneron Pharmaceuticals total assets is $33.08B, an increase of 13.23% to 2022. This figure includes all the resources and properties owned by Regeneron Pharmaceuticals, reflecting its financial standing at that time.
Year | Total Assets | Change |
---|---|---|
2023 | $33.08B | 13.23% |
2022 | $29.21B | 14.86% |
2021 | $25.43B | 48.19% |
2020 | $17.16B | 15.93% |
2019 | $14.81B | 26.17% |
2018 | $11.73B | - |